Rayner Surgical Group

Developer and manufacturer of ophthalmic implants and pharmaceuticals |   www.rayner.com


Date Invested

January 2017





Worthing, UK


Kevin Keck

Rayner is a leading developer and manufacturer of ophthalmic implants and pharmaceuticals. Led by CEO Tim Clover, it specialises in providing intra-ocular lenses and related products used in cataract and refractive surgery that improve the eyesight and quality of patients’ lives. Headquartered in Worthing, United Kingdom, Rayner is a global business with its products available in over 80 countries through its own subsidiaries in the United Kingdom, USA, Italy and Spain and a wide network of distributors. 

our partnership

Phoenix will work with Rayner’s management to accelerate the development of a number of new products, further enhance the Company’s new state of the art production facility in Worthing, strengthen its international reach and support any future strategic acquisition opportunities.

"Our partnership with Phoenix will accelerate our future growth plans providing us with the support and resources to develop and launch new products, contributing to improvements in visual outcomes for surgeons and patients worldwide."

Tim Clover, CEO, Rayner Surgical Group